Oxalate Crystals In Bone Marrow - A Rare Pathological Insight - Pancytopenia Presenting With Fungal Septicemia In A Patient With Undiagnosed Primary Hyperoxaluria.

PANCYTOPENIA PRESENTING WITH FUNGAL SEPTICEMIA IN A PATIENT WITH UNDIAGNOSED PRIMARY HYPEROXALURIA.

  • Safa Javid Shah sher-i-kashmir institute of medical sciences
  • Rumana Hamid Makhdoomi
  • Rukhsana Akhter
  • Roman Latif
Keywords: Primary hyperoxaluria,, oxalosis, crystals, septicemia, pancytopenia

Abstract

Primary hyperoxaluria type 2 (PH2) is a rare autosomal recessive metabolic disorder that can lead to systemic oxalate deposition, particularly in advanced stages. Bone marrow involvement is uncommon and rarely causes clinically significant pancytopenia, though it may increase vulnerability to severe infections in patients with end-stage renal disease (ESRD) on dialysis.

We present a case of a 35-year-old male with PH2 and ESRD who developed fever and pancytopenia. Blood cultures grew Candida parapsilosis, and echocardiography revealed aortic valve vegetation, confirming fungal endocarditis. Bone marrow biopsy showed extensive oxalate crystal deposition replacing hematopoietic tissue. Despite antifungal treatment and catheter removal, the patient suffered an embolic stroke and died.

Bone marrow crystal deposition should be considered in PH2 patients presenting with unexplained pancytopenia. This rare complication can predispose to life-threatening infections, emphasizing the need for timely diagnosis and multidisciplinary management.

Downloads

Download data is not yet available.

References

Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: Understanding the enigma. World Journal of Nephrology. 2015;4(2):235.
Zhu X, Cheung WW, Zhang A, Ding G. Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status. Kidney Diseases. 2024;10(4):313.
Breeggemann MC, Harris PC, Lieske JC, Tasian GE, Wood KD. The Evolving Role of Genetic Testing in Monogenic Kidney Stone Disease: Spotlight on Primary Hyperoxaluria. J Urol. 2024;212(5):649–59.
d’Izarny-Gargas T, Dang J, Grünenwald A, Mechref Z, Besson FL, Ferlicot S, et al. Bone Marrow Oxalosis. Kidney International Reports. 2024;9(4):1139–41.
McCreery RJ, Florescu DF, Kalil AC. Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus. The Journal of Infectious Diseases. 2020;222(Supplement_2):S156–65.
Kashiv P, Dubey S, Sejpal KN, Malde S, Gurjar P, Pasari A, et al. Young Male With End-Stage Renal Disease Due to Primary Hyperoxaluria Type 2: A Rare Presentation. Cureus. 2023;15(10):e46555.
Hoppe B, Kemper MJ, Bökenkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney International. 1999;56(1):268–74.
Bhuyan R, Maggio T, Thomas C, Sambharia M, Gehrs K, Boyce T. Late-onset retinal oxalosis in primary hyperoxaluria type 2. American Journal of Ophthalmology Case Reports. 2024;36:102156.
Flückiger U, Marchetti O, Bille J, Eggimann P, Zimmerli S, Imhof A, et al. Treatment options of invasive fungal infections in adults. Swiss Med Wkly. 2006;136(29–30):447–63.
Published
2025-10-01
How to Cite
1.
Shah S, Makhdoomi R, Akhter R, Latif R. Oxalate Crystals In Bone Marrow - A Rare Pathological Insight - Pancytopenia Presenting With Fungal Septicemia In A Patient With Undiagnosed Primary Hyperoxaluria. jms [Internet]. 2025Oct.1 [cited 2026Oct.2];28(3):15-8. Available from: https://www.jmsskims.org/index.php/jms/article/view/1440
Section
Case Reports